NRX Pharmaceuticals's total assets for Q4 2024 were $3.65M, a decrease of -18.18% from the previous quarter. NRXP total liabilities were $26.87M for the fiscal quarter, a 15.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.